NCT02703337View on ClinicalTrials.gov

A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY900014

Administered subcutaneously (SC)

DRUG

Insulin Lispro

Administered SC

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02703337 - A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection Therapy | Biotech Hunter | Biotech Hunter